- Home
- RCMT vs NYXH Comparison
RCMT vs NYXH Comparison
Compare RCMT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- NYXH
- Stock Information
- Founded
- RCMT 1971
- NYXH 2009
- Country
- RCMT United States
- NYXH Belgium
- Employees
- RCMT N/A
- NYXH 184
- Industry
- RCMT Professional Services
- NYXH Medical/Dental Instruments
- Sector
- RCMT Consumer Discretionary
- NYXH Health Care
- Exchange
- RCMT Nasdaq
- NYXH Nasdaq
- Market Cap
- RCMT 172.2M
- NYXH 196.7M
- IPO Year
- RCMT N/A
- NYXH 2021
- Fundamental
- Price
- RCMT $27.26
- NYXH $5.24
- Analyst Decision
- RCMT Strong Buy
- NYXH Strong Buy
- Analyst Count
- RCMT 2
- NYXH 3
- Target Price
- RCMT $33.50
- NYXH $15.00
- AVG Volume (30 Days)
- RCMT 50.0K
- NYXH 83.6K
- Earning Date
- RCMT 11-06-2025
- NYXH 11-05-2025
- Dividend Yield
- RCMT N/A
- NYXH N/A
- EPS Growth
- RCMT N/A
- NYXH N/A
- EPS
- RCMT 1.76
- NYXH N/A
- Revenue
- RCMT $299,916,000.00
- NYXH $5,793,306.00
- Revenue This Year
- RCMT $15.03
- NYXH $118.20
- Revenue Next Year
- RCMT $7.49
- NYXH $278.04
- P/E Ratio
- RCMT $15.46
- NYXH N/A
- Revenue Growth
- RCMT 11.01
- NYXH 2.94
- 52 Week Low
- RCMT $13.18
- NYXH $5.24
- 52 Week High
- RCMT $28.27
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- RCMT 63.32
- NYXH 27.77
- Support Level
- RCMT $26.00
- NYXH $5.45
- Resistance Level
- RCMT $27.50
- NYXH $6.09
- Average True Range (ATR)
- RCMT 1.13
- NYXH 0.26
- MACD
- RCMT 0.02
- NYXH -0.04
- Stochastic Oscillator
- RCMT 65.88
- NYXH 0.00
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.